Skip Ribbon Commands
Skip to main content

Lymphoma

Relapsed or Refractory Lymphoid Malignancies

  • PSOC 2502: ​A Phase I Study of Bendamustine/Treanda, Rituximab, Etoposide and Carboplatin for Patients with Relapsed or Refractory Lymphoid Malignancies and Select Untreated Lymphomas

For more information, contact Cheryl Patz, RN, OCN, CCRC, at (360) 715-4133​.​​

 
 [+/−]  Feedback